Conversion of a gonadotropin-releasing hormone antagonist to an agonist.
about
Aggregation of complement receptors on human neutrophils in the absence of ligandGonadotropin-releasing hormone receptor microaggregation. Rate monitored by fluorescence resonance energy transfer.Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs.Chaperoning G protein-coupled receptors: from cell biology to therapeuticsLigand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells.Gonadotropin-releasing hormone stimulation of luteinizing hormone release: A ligand-receptor-effector modelA Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH2 versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH2: A Bivalent Advantage.Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptorsPharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease.Evidence that aggregation of mouse sperm receptors by ZP3 triggers the acrosome reaction.Interpretation of dose-response curves for luteinizing hormone release by gonadotropin-releasing hormone, related peptides, and leukotriene C4 according to a hormone/receptor/effector model.Covalent linking of photoreactive gonadotropin-releasing hormone to gonadotropes produces a prolonged signalBench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.Detection of thyroid stimulating (TSAB)- and thyrotropin stimulation blocking (TSBAB) antibodies with CHO cell lines expressing different TSH-receptor numbers.Mathematical modeling of gonadotropin-releasing hormone signalingPotentiation of the antagonistic effect of ACTH11-24 on steroidogenesis by synthesis of covalent dimeric conjugates.Molecular mimicry by antiidiotypic monoclonal antibody to gonadotropin releasing hormone.A mathematical model quantifying GnRH-induced LH secretion from gonadotropes.Pharmacological Chaperones: Potential for the Treatment of Hereditary Diseases Caused by Mutations in G Protein-Coupled ReceptorsGnRH Action
P2860
Q24680114-21291DCB-F7C4-4130-A0AE-720B98766B32Q31466586-8554DD72-5D81-4B57-8941-794DB6676218Q33699210-DDB1A4C3-5A0A-4E1D-83C4-67461B8E4AA1Q33927508-3375D0E8-E3CB-49F1-9451-DC8FCDF1751AQ34017536-63E461A4-684D-40D3-A758-AB081B585095Q34254092-36540774-F98B-4673-90AA-77261A77D7BBQ34550143-01DA039E-CAAB-4DD0-A264-E9FC8741A7B0Q35606973-5E2B231C-099E-432D-8408-3D5BBCD22EE5Q35915771-7F78A31E-7B41-47F1-98E9-014B335E5E44Q36220829-E29A980D-B022-47CA-9569-59A7B82BEDCBQ37394793-2C2F2BF8-6990-4639-B2B3-B29A859688A1Q37607732-93BC1048-6C8C-458E-82BD-DDDAE9545812Q39211934-6DC374F2-BCAD-4972-903C-F268F6574706Q40937545-0DCA3EAF-910C-45C8-8348-B087A8AE3666Q42242396-A812C9F7-A32E-4824-A6D7-96E413023445Q44447476-B7F195F7-9C65-4C8B-8825-5483ADD27901Q48114216-522BC804-CDCA-4D72-8174-5EC17E2414FFQ52082179-EF3358C4-F26F-49FF-85B0-A61DC2669C64Q56648598-136BAFB9-72DA-4767-9217-D1C065B5B95EQ57918892-70B51149-043D-4F9F-BE3C-0B39DE81DBE6
P2860
Conversion of a gonadotropin-releasing hormone antagonist to an agonist.
description
1982 nî lūn-bûn
@nan
1982 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Conversion of a gonadotropin-releasing hormone antagonist to an agonist.
@ast
Conversion of a gonadotropin-releasing hormone antagonist to an agonist.
@en
Conversion of a gonadotropin-releasing hormone antagonist to an agonist.
@nl
type
label
Conversion of a gonadotropin-releasing hormone antagonist to an agonist.
@ast
Conversion of a gonadotropin-releasing hormone antagonist to an agonist.
@en
Conversion of a gonadotropin-releasing hormone antagonist to an agonist.
@nl
prefLabel
Conversion of a gonadotropin-releasing hormone antagonist to an agonist.
@ast
Conversion of a gonadotropin-releasing hormone antagonist to an agonist.
@en
Conversion of a gonadotropin-releasing hormone antagonist to an agonist.
@nl
P2093
P356
P1433
P1476
Conversion of a gonadotropin-releasing hormone antagonist to an agonist.
@en
P2093
P2888
P304
P356
10.1038/296653A0
P407
P577
1982-04-01T00:00:00Z
P6179
1003621349